Matt Revitt
Managing Director, Strategic Services,
Meso Scale
With over 20 years of experience, in various commercial roles in the life sciences industry, Matt Revitt leads a global team at Meso Scale Discovery (MSD) focused on developing partnerships with pharma/biotech companies, medical/academic centers as well as personalized medicine consortia and companies. His team works with MSD clients to implement strategies to enable a streamlined, programmatic and time/cost effective based approach to biomarker discovery, selection and fit for purpose validation. In addition, Matt’s team works with partners on tactical approaches for leveraging new MSD technologies as well as developing and validating large molecule (therapeutic Ab's, vaccines. etc..) ADA, PK as well as pre-clinical and clinical biomarker assays in addition to pre-clinical and clinical sample testing utilizing MSD's unique internal scientific expertise and infrastructure.